Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots.

ABSTRACT: In the present study, we tested whether there were proteomic differences in blood between schizophrenia patients after the initial onset of the disorder and controls; and whether those differences were also present at birth among neonates who later developed schizophrenia compared to those without a psychiatric admission. We used multiple reaction monitoring mass spectrometry to quantify 77 proteins (147 peptides) in serum samples from 60 first-onset drug-naive schizophrenia patients and 77 controls, and 96 proteins (152 peptides) in 892 newborn blood-spot (NBS) samples collected between 1975 and 1985. Both serum and NBS studies showed significant alterations in protein levels. Serum results revealed that Haptoglobin and Plasma protease C1 inhibitor were significantly upregulated in first-

SUBMITTER: Cooper JD 

PROVIDER: S-EPMC5802534 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature